Angeion Corporation (NASDAQ: ANGN) announced that it will release its fiscal 2009 fourth-quarter results on Monday, December 14, 2009, at market close. Following the release, the company will hold an investment community conference call on the same day, beginning at 4:00 p.m. CST. Rodney Young, President and CEO, and William Kullback, SVP and CFO, will [...]

Continue reading " Angeion to Announce 2009 Fourth-Quarter Results on Monday, December 14 "

RXi Pharmaceuticals Corporation (Nasdaq: RXII), a biopharmaceutical company pursuing the development and commercialization of proprietary therapeutics based on RNA interference (RNAi), reported its financial results for the quarter ended September 30, 2009. Related posts Medical Health Insurance in Florida: Allegiance Financial Notes Many Finding Better Coverage by Leaving Their Employer Plans Behind (0) China Pharmaceuticals, [...]

Continue reading " RXi Pharmaceuticals Reports Financial Results for the Third Quarter of 2009 "

Targeted Genetics Corporation (NASDAQ: TGEN) today its financial results for the third quarter ended September 30, 2009. For the quarter ended September 30, 2009, the Company reported net income of $671,000, or $0.03 per common share, compared to a net loss of $2.7 million, or $0.13 per common share, for the third quarter of 2008. [...]

Continue reading " Targeted Genetics Corporation Reports Third Quarter 2009 Financial Results "

ZOLL Medical Corporation (NasdaqGS: ZOLL), a manufacturer of resuscitation devices and software solutions, announced that fiscal 2009 revenues were $385.2 million, compared to fiscal 2008 revenues of $398.0 million, a decline of 3%. Revenue results reflected a negative foreign exchange impact of nearly $12 million compared to fiscal 2008. The results include approximately $6.9 million [...]

Continue reading " ZOLL Medical Corporation Announces Annual Results "